FDA Social Media Compliance 2025: Navigating Drug & Device Marketing Risks
Navigate New FDA Guidelines to Promote Safely, Responsibly, and Compliantly!
Instructor :
Carolyn Troiano
Webinar ID:
12528
Date: JUN 16, 2025 (MON)
Start Time: 10 AM PT - 11:30 AM PT
Duration: 90 Mins.
Buy This Course in a Pack of 2 courses at 25% Discount HERE:
The Compliance & Documentation Essentials Pack (Pack of 2)
“Stay Ahead in Regulatory Compliance and Document Control!”
2 Courses Included:
Why This Pack?
Equip yourself with critical knowledge in two rapidly evolving areas: social media regulation and data integrity for spreadsheet use in FDA-regulated environments. With an increasing emphasis on digital and social media data in regulatory compliance, these courses are designed to help compliance officers and documentation managers adapt to new requirements efficiently.
Target Audience: Compliance Managers, Quality Assurance Specialists, Documentation Managers
Why Buy the Pack?
-
- Cross-Cutting Compliance Insight: Address two crucial, high-impact areas of compliance in one purchase.
Buy This Course in a Pack of 2 courses at 25% Discount HERE:
“Stay Ahead in Regulatory Compliance and Document Control!”
2 Courses Included:
Why This Pack?
Equip yourself with critical knowledge in two rapidly evolving areas: social media regulation and data integrity for spreadsheet use in FDA-regulated environments. With an increasing emphasis on digital and social media data in regulatory compliance, these courses are designed to help compliance officers and documentation managers adapt to new requirements efficiently.
Target Audience: Compliance Managers, Quality Assurance Specialists, Documentation Managers
Why Buy the Pack?
-
- Cross-Cutting Compliance Insight: Address two crucial, high-impact areas of compliance in one purchase.
- Save & Stay Compliant: Gain significant savings while ensuring that all aspects of digital and documentation regulations are met.
- Actionable Knowledge: Gain immediately applicable strategies to avoid non-compliance in social media and data documentation.
Note: Do you want to custom design your pack and choose courses of your choice? Just drop us an email at support@compliancemeet.com or call at Toll Free: +1 (888) 959-4972. We’ll be happy to help you!
Buy Both Courses at a 25% discount HERE
What will you learn
-
- Pros And Cons Of Social Media In Regulated Industries
- Creating FDA-Compliant Social Media Content For Drug And Device Marketing
- Understanding And Applying The Latest FDA Guidance Documents
- Balancing Benefit-Risk Information Within Social Media Guidelines
- Conveying Compliance Within Character Limits On Social Media
- Monitoring And Addressing Third-Party Misinformation ….
-
- Pros And Cons Of Social Media In Regulated Industries
- Creating FDA-Compliant Social Media Content For Drug And Device Marketing
- Understanding And Applying The Latest FDA Guidance Documents
- Balancing Benefit-Risk Information Within Social Media Guidelines
- Conveying Compliance Within Character Limits On Social Media
- Monitoring And Addressing Third-Party Misinformation Effectively
- Preparing For Upcoming Congressional Regulatory Actions Impacting Social Media
Course Description
In today’s fast-paced digital world, staying compliant with FDA regulations on social media marketing is more critical than ever.
This 90-minute webinar provides a comprehensive overview of the FDA’s latest guidance on promoting drug products and medical devices via social platforms.
Led by a seasoned industry expert, this session breaks down the complex regulatory landscape into clear, actionable strategies to help you remain compliant while maximizing your digital outreach.
Whether you’re part of a marketing team, regulatory affairs, or legal counsel, this course equips you with the knowledge to navigate the fine line between promotion and violation.
Key learning objectives include:
-
- Understanding the scope and limitations of FDA’s social media guidance
- Crafting compliant content that clearly communicates product benefits, risks, and usage
- Developing robust internal policies and procedures to mitigate regulatory risk
- Applying real-world examples of successful and compliant social media campaigns
- Identifying common pitfalls and how to avoid them proactively
This session also offers critical insights for consultants working in the tobacco and life sciences sectors, particularly those involved in computer system implementation, validation, and compliance.
Gain the confidence to align your organization’s digital marketing efforts with FDA expectations—without compromising innovation or engagement.
Enroll Now!
In today’s fast-paced digital world, staying compliant with FDA regulations on social media marketing is more critical than ever.
This 90-minute webinar provides a comprehensive overview of the FDA’s latest guidance on promoting drug products and medical devices via social platforms.
Led by a seasoned industry expert, this session breaks down the complex regulatory landscape into clear, actionable strategies to help you remain compliant while maximizing your digital outreach.
Whether you’re part of a marketing team, regulatory affairs, or legal counsel, this course equips you with the knowledge to navigate the fine line between promotion and violation.
Key learning objectives include:
-
- Understanding the scope and limitations of FDA’s social media guidance
- Crafting compliant content that clearly communicates product benefits, risks, and usage
- Developing robust internal policies and procedures to mitigate regulatory risk
- Applying real-world examples of successful and compliant social media campaigns
- Identifying common pitfalls and how to avoid them proactively
This session also offers critical insights for consultants working in the tobacco and life sciences sectors, particularly those involved in computer system implementation, validation, and compliance.
Gain the confidence to align your organization’s digital marketing efforts with FDA expectations—without compromising innovation or engagement.
Enroll Now!
Why you should attend
The FDA’s new social media guidelines mark a turning point in how companies can communicate about drug products and medical devices online.
For professionals in the pharmaceutical, medical device, and tobacco industries, staying compliant with these updated standards is no longer optional—it’s essential to protect your organization from costly regulatory repercussions.
This 90-minute webinar will empower you to understand and apply the latest FDA guidelines to your social media strategy, ensuring that your content meets regulatory standards without compromising effectiveness.
The skills and insights gained in this session will directly impact how you approach social media, helping you to:
-
- Reduce legal risks by aligning your social media practices with FDA expectations, ensuring every post, tweet, or campaign complies with regulatory demands.
- Build credibility and trust with consumers and stakeholders through transparent, compliant communication.
- Strengthen your strategic planning for social media, allowing you to confidently develop compliant content strategies and avoid pitfalls.
Beyond simply understanding compliance, this session is crucial for consultants, marketers, and regulatory professionals responsible for maintaining a secure, compliant social media presence.
With real-world examples and practical insights, you’ll leave equipped to address common challenges and make informed decisions in an environment where digital marketing meets stringent regulation.
Take charge of your social media compliance with FDA-approved best practices, safeguard your organization, and become an asset in your role with these essential skills.
Join Now!
The FDA’s new social media guidelines mark a turning point in how companies can communicate about drug products and medical devices online.
For professionals in the pharmaceutical, medical device, and tobacco industries, staying compliant with these updated standards is no longer optional—it’s essential to protect your organization from costly regulatory repercussions.
This 90-minute webinar will empower you to understand and apply the latest FDA guidelines to your social media strategy, ensuring that your content meets regulatory standards without compromising effectiveness.
The skills and insights gained in this session will directly impact how you approach social media, helping you to:
-
- Reduce legal risks by aligning your social media practices with FDA expectations, ensuring every post, tweet, or campaign complies with regulatory demands.
- Build credibility and trust with consumers and stakeholders through transparent, compliant communication.
- Strengthen your strategic planning for social media, allowing you to confidently develop compliant content strategies and avoid pitfalls.
Beyond simply understanding compliance, this session is crucial for consultants, marketers, and regulatory professionals responsible for maintaining a secure, compliant social media presence.
With real-world examples and practical insights, you’ll leave equipped to address common challenges and make informed decisions in an environment where digital marketing meets stringent regulation.
Take charge of your social media compliance with FDA-approved best practices, safeguard your organization, and become an asset in your role with these essential skills.
Join Now!
Areas Covered
1. The Strategic Role of Social Media in Regulated Industries
-
- Evaluate the benefits and risks of using social platforms for drug and device promotion
- Identify platform-specific considerations for compliance and audience engagement
2. Navigating FDA Regulations in the Digital Space
-
- Understand the scope of FDA’s oversight on online promotional content
- Interpret FDA expectations for compliant social media practices
3. Decoding FDA Draft Guidance on Social Media Use
-
- Analyze the most recent FDA draft guidance documents
- Learn how to translate regulatory language into practical marketing steps
4. Communicating Benefits and Risks Effectively
-
- Explore strategies to ensure balanced presentation of product claims
- Understand the regulatory requirement for fair balance in messaging
5. Managing Social Media’s Character Space Limitations
-
- Discover best practices for condensing key messages within strict character limits (e.g., Twitter)
- Ensure transparency and compliance without sacrificing message clarity
6. Responding to Third-Party Misinformation
-
- Learn how to address unauthorized or incorrect third-party content
- Maintain compliance while protecting brand integrity
7. Preparing for Future Regulatory Developments
-
- Review potential legislative and FDA changes impacting digital marketing
- Develop adaptive strategies to future-proof your compliance efforts
BONUS:
-
- PDF copy of the presentation handout for your future reference.
- Soft copy of the certificate of completion on request.
- Q&A Session with the Presenter: Get your pressing questions answered verbally, via chat or email
1. The Strategic Role of Social Media in Regulated Industries
-
- Evaluate the benefits and risks of using social platforms for drug and device promotion
- Identify platform-specific considerations for compliance and audience engagement
2. Navigating FDA Regulations in the Digital Space
-
- Understand the scope of FDA’s oversight on online promotional content
- Interpret FDA expectations for compliant social media practices
3. Decoding FDA Draft Guidance on Social Media Use
-
- Analyze the most recent FDA draft guidance documents
- Learn how to translate regulatory language into practical marketing steps
4. Communicating Benefits and Risks Effectively
-
- Explore strategies to ensure balanced presentation of product claims
- Understand the regulatory requirement for fair balance in messaging
5. Managing Social Media’s Character Space Limitations
-
- Discover best practices for condensing key messages within strict character limits (e.g., Twitter)
- Ensure transparency and compliance without sacrificing message clarity
6. Responding to Third-Party Misinformation
-
- Learn how to address unauthorized or incorrect third-party content
- Maintain compliance while protecting brand integrity
7. Preparing for Future Regulatory Developments
-
- Review potential legislative and FDA changes impacting digital marketing
- Develop adaptive strategies to future-proof your compliance efforts
BONUS:
-
- PDF copy of the presentation handout for your future reference.
- Soft copy of the certificate of completion on request.
- Q&A Session with the Presenter: Get your pressing questions answered verbally, via chat or email
Who is this course for
Everybody Benefits from Watching This. Even Better When Done as a Group!
-
- Marketing Leaders Aiming to Ensure Social Media Compliance
- Regulatory Affairs Specialists Focused on Reducing Risk Exposure
- Compliance Managers Striving to Mitigate Social Media Liabilities
- Training Heads Crafting Tailored Compliance Programs for Teams
- Legal Advisors Assisting in Regulatory Compliance
- Product Managers Overseeing Digital Promotions for Regulated Products
- HR Professionals Looking to Strengthen Regulatory Training
- Social Media Managers Creating Content within FDA Guidelines
- Consultants in Life Sciences and Tobacco Industries
Everybody Benefits from Watching This. Even Better When Done as a Group!
-
- Marketing Leaders Aiming to Ensure Social Media Compliance
- Regulatory Affairs Specialists Focused on Reducing Risk Exposure
- Compliance Managers Striving to Mitigate Social Media Liabilities
- Training Heads Crafting Tailored Compliance Programs for Teams
- Legal Advisors Assisting in Regulatory Compliance
- Product Managers Overseeing Digital Promotions for Regulated Products
- HR Professionals Looking to Strengthen Regulatory Training
- Social Media Managers Creating Content within FDA Guidelines
- Consultants in Life Sciences and Tobacco Industries
Instructor Profile
Carolyn (McKillop) Troiano has more than 40 years of experience in the tobacco, pharmaceutical, medical device and other FDA-regulated industries. She has worked directly, or on a consulting basis, for many of the larger pharmaceutical and tobacco companies in the US and Europe, developing and executing compliance strategies and programs. Carolyn is currently active in the Association of Information Technology Professionals (AITP), and Project Management Institute (PMI) chapters in the Richmond, VA area.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.
